151 related articles for article (PubMed ID: 38856135)
21. Pregabalin for acute and chronic pain in adults.
Moore RA; Straube S; Wiffen PJ; Derry S; McQuay HJ
Cochrane Database Syst Rev; 2009 Jul; (3):CD007076. PubMed ID: 19588419
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial.
Srinivasan A; Dutta P; Bansal D; Chakrabarti A; Bhansali AK; Hota D
J Diabetes; 2021 Oct; 13(10):770-778. PubMed ID: 34014028
[TBL] [Abstract][Full Text] [Related]
23. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
Arnold LM; McCarberg BH; Clair AG; Whalen E; Thomas N; Jorga A; Pauer L; Vissing R; Park PW
Postgrad Med; 2017 Nov; 129(8):921-933. PubMed ID: 28967801
[TBL] [Abstract][Full Text] [Related]
24. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.
Morello CM; Leckband SG; Stoner CP; Moorhouse DF; Sahagian GA
Arch Intern Med; 1999 Sep; 159(16):1931-7. PubMed ID: 10493324
[TBL] [Abstract][Full Text] [Related]
25. Nortriptyline for neuropathic pain in adults.
Derry S; Wiffen PJ; Aldington D; Moore RA
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011209. PubMed ID: 25569864
[TBL] [Abstract][Full Text] [Related]
26. Antidepressants for chronic non-cancer pain in children and adolescents.
Cooper TE; Heathcote LC; Clinch J; Gold JI; Howard R; Lord SM; Schechter N; Wood C; Wiffen PJ
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012535. PubMed ID: 28779487
[TBL] [Abstract][Full Text] [Related]
27. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
[TBL] [Abstract][Full Text] [Related]
28. Identification of patients with painful diabetic peripheral neuropathy who have a favorable cost profile with pregabalin treatment.
Udall M; Mardekian J; Cabrera J
Pain Pract; 2013 Jul; 13(6):476-84. PubMed ID: 23150918
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta-analysis.
Zhang SS; Wu Z; Zhang LC; Zhang Z; Chen RP; Huang YH; Chen H
Acta Anaesthesiol Scand; 2015 Feb; 59(2):147-59. PubMed ID: 25328117
[TBL] [Abstract][Full Text] [Related]
30. Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials.
Shanthanna H; Gilron I; Rajarathinam M; AlAmri R; Kamath S; Thabane L; Devereaux PJ; Bhandari M
PLoS Med; 2017 Aug; 14(8):e1002369. PubMed ID: 28809936
[TBL] [Abstract][Full Text] [Related]
31. Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
[TBL] [Abstract][Full Text] [Related]
32. Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover Study.
Raskin P; Huffman C; Yurkewicz L; Pauer L; Scavone JM; Yang R; Parsons B
Clin J Pain; 2016 Mar; 32(3):203-10. PubMed ID: 25968451
[TBL] [Abstract][Full Text] [Related]
33. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
Max MB; Lynch SA; Muir J; Shoaf SE; Smoller B; Dubner R
N Engl J Med; 1992 May; 326(19):1250-6. PubMed ID: 1560801
[TBL] [Abstract][Full Text] [Related]
34. Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.
Raskin P; Huffman C; Toth C; Asmus MJ; Messig M; Sanchez RJ; Pauer L
Clin J Pain; 2014 May; 30(5):379-90. PubMed ID: 23887339
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of pregabalin for treating pain associated with diabetic peripheral neuropathy in subjects with type 1 or type 2 diabetes mellitus.
Parsons B; Li C; Emir B; Vinik AI
Curr Med Res Opin; 2018 Nov; 34(11):2015-2022. PubMed ID: 30084288
[TBL] [Abstract][Full Text] [Related]
36. Pregabalin for painful diabetic peripheral neuropathy: strategies for dosing, monotherapy vs. combination therapy, treatment-refractory patients, and adverse events.
Juhn MS; Parsons B; Varvara R; Sadosky A
Curr Med Res Opin; 2015 May; 31(5):1017-26. PubMed ID: 25772233
[TBL] [Abstract][Full Text] [Related]
37. Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials.
Onakpoya IJ; Thomas ET; Lee JJ; Goldacre B; Heneghan CJ
BMJ Open; 2019 Jan; 9(1):e023600. PubMed ID: 30670513
[TBL] [Abstract][Full Text] [Related]
38. Duloxetine in Painful Diabetic Neuropathy: A Systematic Review.
Hossain SM; Hussain SM; Ekram AR
Clin J Pain; 2016 Nov; 32(11):1005-1010. PubMed ID: 26710221
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis of the preoperative use of gabapentinoids for the treatment of acute postoperative pain following spinal surgery.
Liu B; Liu R; Wang L
Medicine (Baltimore); 2017 Sep; 96(37):e8031. PubMed ID: 28906391
[TBL] [Abstract][Full Text] [Related]
40. Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment.
Edwards RA; Bonfanti G; Grugni R; Manca L; Parsons B; Alexander J
Adv Ther; 2018 Oct; 35(10):1585-1597. PubMed ID: 30206821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]